Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis

Authors:

Abstract
No abstract available
Funding Information
  • European Social Fund Plus
  • Eesti Teadusagentuur (PRG1095)
  • Eesti Teadusagentuur (RITA1/02-96-11)
  • Innovative Medicines Initiative (806968)
  • Departament de Salut, Generalitat de Catalunya (SLT002/16/00308)
  • European Commission
  • GlaxoSmithKline
  • National Institute for Health and Care Research
  • Medical Research Council
  • European Federation of Pharmaceutical Industries and Associations

This publication has 27 references indexed in Scilit: